Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (20)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Sweeney, L. M.
Right arrow Articles by Gargas, M. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sweeney, L. M.
Right arrow Articles by Gargas, M. L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Toxicological Sciences 62, 124-139 (2001)
Copyright © 2001 by the Society of Toxicology


RISK ASSESSMENT

Proposed Occupational Exposure Limits for Select Ethylene Glycol Ethers Using PBPK Models and Monte Carlo Simulations

L. M. Sweeney*,1, T. R. Tyler{dagger}, C. R. Kirman{ddagger}, R. A. Corley§, R. H. Reitz, D. J. Paustenbach||, J. F. Holson|||, M. D. Whorton||||, K. M. Thompson# and M. L. Gargas*

* The Sapphire Group, Inc., 2928 Idaho Falls Drive, Suite 100, Beavercreek, Ohio 45431; {dagger} Union Carbide Corporation, Danbury, Connecticut; {ddagger} The Sapphire Group, Inc., Cleveland, Ohio; § Battelle, Richland, Washington; RHR Toxicology, Midland, Michigan; || Exponent, Menlo Park, California; ||| WIL Laboratories, Ashland, Ohio; |||| M. Donald Whorton, M.D., Inc., Alameda, California; and # Harvard School of Public Health, Boston, Massachusetts

ABSTRACT

Methoxyethanol (ethylene glycol monomethyl ether, EGME), ethoxyethanol (ethylene glycol monoethyl ether, EGEE), and ethoxyethyl acetate (ethylene glycol monoethyl ether acetate, EGEEA) are all developmental toxicants in laboratory animals. Due to the imprecise nature of the exposure data in epidemiology studies of these chemicals, we relied on human and animal pharmacokinetic data, as well as animal toxicity data, to derive 3 occupational exposure limits (OELs). Physiologically based pharmacokinetic (PBPK) models for EGME, EGEE, and EGEEA in pregnant rats and humans have been developed (M. L. Gargas et al., 2000, Toxicol. Appl. Pharmacol. 165, 53–62; M. L. Gargas et al., 2000, Toxicol. Appl. Pharmacol. 165, 63–73). These models were used to calculate estimated human-equivalent no adverse effect levels (NAELs), based upon internal concentrations in rats exposed to no observed effect levels (NOELs) for developmental toxicity. Estimated NAEL values of 25 ppm for EGEEA and EGEE and 12 ppm for EGME were derived using average values for physiological, thermodynamic, and metabolic parameters in the PBPK model. The uncertainties in the point estimates for the NOELs and NAELs were estimated from the distribution of internal dose estimates obtained by varying key parameter values over expected ranges and probability distributions. Key parameters were identified through sensitivity analysis. Distributions of the values of these parameters were sampled using Monte Carlo techniques and appropriate dose metrics calculated for 1600 parameter sets. The 95th percentile values were used to calculate interindividual pharmacokinetic uncertainty factors (UFs) to account for variability among humans (UFh,pk). These values of 1.8 for EGEEA/EGEE and 1.7 for EGME are less than the default value of 3 for this area of uncertainty. The estimated human equivalent NAELs were divided by UFh,pk and the default UFs for pharmacodynamic variability among animals and among humans to calculate the proposed OELs. This methodology indicates that OELs (8-h time-weighted average) that should protect workers from the most sensitive adverse effects of these chemicals are 2 ppm EGEEA and EGEE (11 mg/m3 EGEEA, 7 mg/m3 EGEE) and 0.9 ppm (3 mg/m3) EGME. These recommendations assume that dermal exposure will be minimal or nonexistent.

Key Words: occupational exposure limit; ethoxyethyl acetate; ethoxyethanol; methoxyethanol; EGEEA; EGEE; EGME; PBPK models; Monte Carlo simulation.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Antimicrob. Agents Chemother.Home page
J. Buur, R. Baynes, G. Smith, and J. Riviere
Use of Probabilistic Modeling within a Physiologically Based Pharmacokinetic Model To Predict Sulfamethazine Residue Withdrawal Times in Edible Tissues in Swine.
Antimicrob. Agents Chemother., July 1, 2006; 50(7): 2344 - 2351.
[Abstract] [Full Text] [PDF]


Home page
International Journal of ToxicologyHome page
M. Koontz, P. Price, J. Hamilton, D. Daggett, R. Sielken, R. Bretzlaff, and T. Tyler
Modeling Aggregate Exposures to Glycol Ethers from Use of Commercial Floor Products
International Journal of Toxicology, March 1, 2006; 25(2): 95 - 107.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
C. Emond, L. S. Birnbaum, and M. J. DeVito
Physiologically Based Pharmacokinetic Model for Developmental Exposures to TCDD in the Rat
Toxicol. Sci., July 1, 2004; 80(1): 115 - 133.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
L. M. Sweeney, M. E. Andersen, and M. L. Gargas
Ethyl Acrylate Risk Assessment with a Hybrid Computational Fluid Dynamics and Physiologically Based Nasal Dosimetry Model
Toxicol. Sci., June 1, 2004; 79(2): 394 - 403.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.